Issue 9 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

29

No.

9

September 29, 2006Sep 29, 2006

Free

DOWNLOAD THE PDF

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

Long-Term Remissions Shown With Chemo Plus Radiation

Raloxifene Protects Women At High or Low Risk of Disease

Study Needs 23,000 Women Whose Sisters Have Cancer

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

Breast Density As Important As Age In Determining Risk

Ovariectomy Without HRT Increases Death Rate

NCI-Approved Clinical Trials

Recent Issues

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025